Cargando…

Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report

Patient: Male, 62-year-old Final Diagnosis: BCGitis Symptoms: Fever • general fatigue Medication: — Clinical Procedure: Bone marrow biopsy • liver biopsy Specialty: Infectious Diseases • General and Internal Medicine OBJECTIVE: Rare coexistence of disease or pathology BACKGROUND: Bladder cancer (BC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallilas, Christos, Zachou, Maria, Dolkiras, Philippos, Sakellariou, Stratigoula, Constantinou, Costas A., Flevari, Pagona, Anastasopoulou, Amalia, Androutsakos, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525903/
https://www.ncbi.nlm.nih.gov/pubmed/34654796
http://dx.doi.org/10.12659/AJCR.933006
_version_ 1784585776889069568
author Vallilas, Christos
Zachou, Maria
Dolkiras, Philippos
Sakellariou, Stratigoula
Constantinou, Costas A.
Flevari, Pagona
Anastasopoulou, Amalia
Androutsakos, Theodoros
author_facet Vallilas, Christos
Zachou, Maria
Dolkiras, Philippos
Sakellariou, Stratigoula
Constantinou, Costas A.
Flevari, Pagona
Anastasopoulou, Amalia
Androutsakos, Theodoros
author_sort Vallilas, Christos
collection PubMed
description Patient: Male, 62-year-old Final Diagnosis: BCGitis Symptoms: Fever • general fatigue Medication: — Clinical Procedure: Bone marrow biopsy • liver biopsy Specialty: Infectious Diseases • General and Internal Medicine OBJECTIVE: Rare coexistence of disease or pathology BACKGROUND: Bladder cancer (BC) is the second most common cancer involving the urinary system. In non-muscle-invading BC, transurethral resection of a bladder tumor followed by intravesical immunotherapy with Bacillus Calmette-Guérin (BCG) is the usual treatment. Disseminated (or systemic) BCG infection (BCGitis) represents the most severe adverse effect of intravesical BCG therapy, presenting with high-grade fever, with or without symptoms in the urinary tract, leading to severe sepsis and death if left untreated. The treatment of choice consists of isoniazid, rifampicin, and ethambutol (with or without corticosteroids) for 6 months, and the recovery rate is extremely high. Given the fact that these drugs are hepatotoxic, treating a patient with liver cirrhosis is challenging. CASE REPORT: We present a patient with a medical history of BC treated with transurethral resection and intravesical BCG therapy, presenting with fever, transaminasemia, and generalized weakness. Liver and bone marrow biopsies revealed liver cirrhosis and granulomas in both organs. A diagnose of BCGitis was made and the patient was treated with isoniazid, rifampicin, and ethambutol; rifampicin was substituted with moxifloxacin after 1 month due to worsening of liver laboratory results, and moxifloxacin was substituted with levofloxacin later on due to tonic-clonic seizures. The patient was treated for 4 more months with levofloxacin and for 7 more months with isoniazid and ethambutol, with no other adverse effects, preserving liver function and achieving cure of BCGitis. CONCLUSIONS: We present the case of a cirrhotic patient presenting with fever and deterioration of liver laboratory results, found to have BCGitis, and discuss possible difficulties in diagnosing and treating such patients.
format Online
Article
Text
id pubmed-8525903
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-85259032021-11-09 Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report Vallilas, Christos Zachou, Maria Dolkiras, Philippos Sakellariou, Stratigoula Constantinou, Costas A. Flevari, Pagona Anastasopoulou, Amalia Androutsakos, Theodoros Am J Case Rep Articles Patient: Male, 62-year-old Final Diagnosis: BCGitis Symptoms: Fever • general fatigue Medication: — Clinical Procedure: Bone marrow biopsy • liver biopsy Specialty: Infectious Diseases • General and Internal Medicine OBJECTIVE: Rare coexistence of disease or pathology BACKGROUND: Bladder cancer (BC) is the second most common cancer involving the urinary system. In non-muscle-invading BC, transurethral resection of a bladder tumor followed by intravesical immunotherapy with Bacillus Calmette-Guérin (BCG) is the usual treatment. Disseminated (or systemic) BCG infection (BCGitis) represents the most severe adverse effect of intravesical BCG therapy, presenting with high-grade fever, with or without symptoms in the urinary tract, leading to severe sepsis and death if left untreated. The treatment of choice consists of isoniazid, rifampicin, and ethambutol (with or without corticosteroids) for 6 months, and the recovery rate is extremely high. Given the fact that these drugs are hepatotoxic, treating a patient with liver cirrhosis is challenging. CASE REPORT: We present a patient with a medical history of BC treated with transurethral resection and intravesical BCG therapy, presenting with fever, transaminasemia, and generalized weakness. Liver and bone marrow biopsies revealed liver cirrhosis and granulomas in both organs. A diagnose of BCGitis was made and the patient was treated with isoniazid, rifampicin, and ethambutol; rifampicin was substituted with moxifloxacin after 1 month due to worsening of liver laboratory results, and moxifloxacin was substituted with levofloxacin later on due to tonic-clonic seizures. The patient was treated for 4 more months with levofloxacin and for 7 more months with isoniazid and ethambutol, with no other adverse effects, preserving liver function and achieving cure of BCGitis. CONCLUSIONS: We present the case of a cirrhotic patient presenting with fever and deterioration of liver laboratory results, found to have BCGitis, and discuss possible difficulties in diagnosing and treating such patients. International Scientific Literature, Inc. 2021-10-16 /pmc/articles/PMC8525903/ /pubmed/34654796 http://dx.doi.org/10.12659/AJCR.933006 Text en © Am J Case Rep, 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Vallilas, Christos
Zachou, Maria
Dolkiras, Philippos
Sakellariou, Stratigoula
Constantinou, Costas A.
Flevari, Pagona
Anastasopoulou, Amalia
Androutsakos, Theodoros
Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report
title Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report
title_full Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report
title_fullStr Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report
title_full_unstemmed Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report
title_short Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report
title_sort difficulties in diagnosing and treating disseminated bacillus calmette-guérin (bcg) infection after intravesical bcg therapy in a patient with liver cirrhosis: a case report
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525903/
https://www.ncbi.nlm.nih.gov/pubmed/34654796
http://dx.doi.org/10.12659/AJCR.933006
work_keys_str_mv AT vallilaschristos difficultiesindiagnosingandtreatingdisseminatedbacilluscalmetteguerinbcginfectionafterintravesicalbcgtherapyinapatientwithlivercirrhosisacasereport
AT zachoumaria difficultiesindiagnosingandtreatingdisseminatedbacilluscalmetteguerinbcginfectionafterintravesicalbcgtherapyinapatientwithlivercirrhosisacasereport
AT dolkirasphilippos difficultiesindiagnosingandtreatingdisseminatedbacilluscalmetteguerinbcginfectionafterintravesicalbcgtherapyinapatientwithlivercirrhosisacasereport
AT sakellarioustratigoula difficultiesindiagnosingandtreatingdisseminatedbacilluscalmetteguerinbcginfectionafterintravesicalbcgtherapyinapatientwithlivercirrhosisacasereport
AT constantinoucostasa difficultiesindiagnosingandtreatingdisseminatedbacilluscalmetteguerinbcginfectionafterintravesicalbcgtherapyinapatientwithlivercirrhosisacasereport
AT flevaripagona difficultiesindiagnosingandtreatingdisseminatedbacilluscalmetteguerinbcginfectionafterintravesicalbcgtherapyinapatientwithlivercirrhosisacasereport
AT anastasopoulouamalia difficultiesindiagnosingandtreatingdisseminatedbacilluscalmetteguerinbcginfectionafterintravesicalbcgtherapyinapatientwithlivercirrhosisacasereport
AT androutsakostheodoros difficultiesindiagnosingandtreatingdisseminatedbacilluscalmetteguerinbcginfectionafterintravesicalbcgtherapyinapatientwithlivercirrhosisacasereport